- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03082612
Faith-Based African American Cancer Survivorship Storytelling
Faith-Based African American Cancer Survivorship Storytelling: A Culturally Relevant Intervention to Alleviate Psychological Stress
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Georgia
-
Atlanta, Georgia, United States, 30303
- Grady Cancer Center for Excellence
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria for Patients:
- Age 30-89 years
- Newly diagnosed with any stage cancer
- Treatment plans to include weekly outpatient chemotherapy
- Previously screened and with greater than 0 level of psychological distress
- Willingness to participate in all study activities including data collection
- Willing to identify a family caregiver (FCG) (immediate or extended family member) to also participate
Exclusion Criteria for Patients:
- Have completed surgery with no plans for chemotherapy
- Find conversations around religion or spirituality emotionally upsetting
- Have completed more than half of prescribed chemotherapy treatments
- In hospice care
- Not able to provide informed consent
Inclusion Criteria for Family Caregiver:
- Immediate or extended family member of the patient
- 18 years of age or older
- Able to provide informed consent
- Willing to participate in study activities, including data collection
Exclusion Criteria for Family Caregiver:
- Find conversations around religion or spirituality emotionally upsetting
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: African American cancer patients
Patients will be required to participate in intervention activities and 5 data collection interviews.
Interviews to complete both open-ended interviews and quantitative measures will take approximately 45 minutes.
The actual administration of the intervention (viewing of video recordings) will take approximately 30 minutes with all sessions to occur over a 3 week period.
|
The intervention will consist of participants viewing a selection of video recorded vignettes during 3 weekly sessions.
There will be 5 vignettes included in each session with each vignette edited to a real time of 3-4 minutes (each session is 30 minutes).
Since the intervention is designed to be self-administered, there will be a video recorded introduction and instructions for use narrated by the PI.
The vignettes are of actual African American cancer survivors narrating stories of ways in which hymns can be used to overcome their anxieties and depressed moods through the use of a hymn.
The hymns included represent exemplars from the 5 themes prevalent in the PI's previous research
Other Names:
|
|
Experimental: Family caregivers
Family caregivers will be required to participate in intervention activities and 5 data collection interviews.
Interviews to complete both open-ended interviews and quantitative measures will take approximately 45 minutes.
The actual administration of the intervention (viewing of video recordings) will take approximately 30 minutes with all sessions to occur over a 3 week period.
|
The intervention will consist of participants viewing a selection of video recorded vignettes during 3 weekly sessions.
There will be 5 vignettes included in each session with each vignette edited to a real time of 3-4 minutes (each session is 30 minutes).
Since the intervention is designed to be self-administered, there will be a video recorded introduction and instructions for use narrated by the PI.
The vignettes are of actual African American cancer survivors narrating stories of ways in which hymns can be used to overcome their anxieties and depressed moods through the use of a hymn.
The hymns included represent exemplars from the 5 themes prevalent in the PI's previous research
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hospital Anxiety and Depression Scale (HADS) Score
Time Frame: Baseline, Week 3 post-intervention
|
Psychological distress for patients and family caregivers (FCGs) will be measured with the Hospital Anxiety and Depression Scale (HADS). Scoring for the Anxiety and Depression scale of the HADS is (0-21); Normal (0-7); Borderline Abnormal Case (8-10); and Abnormal Case (11-21). Higher score correlates with worse outcome. |
Baseline, Week 3 post-intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Supportive Family Relationships (Mutuality) Scale Score
Time Frame: Baseline, Week 3 post-intervention
|
Mutuality is measured with the scale "You, Your Family and Friends" that measures the degree of positive relationships among participants and their family and friends.
This scale measures the degree to which the caregiver-care receiver relationship was characterized by love, shared values, shared pleasurable activities, and reciprocity.
The adapted scale has 12-items with a 5-point response format.
A mean of responses with a range of 0 to 5 will be reported.
Higher scores are indicative of better outcomes, indicating engagement in positive supportive relationships with family and friends.
|
Baseline, Week 3 post-intervention
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Jill B Hamilton, PhD, RN, Emory University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- IRB00093110
- 5R03MD013509-02 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer
-
Cellworks Group Inc.RecruitingCancer | Relapsed Cancer | Refractory CancerUnited States
-
Yale UniversityNational Institute of Nursing Research (NINR); The Glimpse Group IncRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
University of Michigan Rogel Cancer CenterCompletedCancer Liver | Cancer Brain | Cancer Head &Neck | Cancer PelvisUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI); Atrium Health Wake Forest BaptistRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
Vanderbilt-Ingram Cancer CenterEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedAdvanced Cancer | Relapsed Cancer | Refractory CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IV Gastric Cancer | Stage IVA Colorectal Cancer | Stage IVA Pancreatic Cancer | Stage IVB Colorectal Cancer | Stage IVB Pancreatic Cancer | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric... and other conditionsUnited States
-
Second Affiliated Hospital of Soochow UniversityNot yet recruitingCancer | Solid Cancer
-
New Mexico Cancer Research AllianceOhio State University Comprehensive Cancer Center; H. Lee Moffitt Cancer Center...RecruitingCancer | Cancer RiskUnited States
-
Children's Hospital of PhiladelphiaCompletedCancer | Childhood CancerUnited States
-
University of California, San FranciscoBristol-Myers Squibb; PfizerTerminatedStage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Metastatic Colorectal Adenocarcinoma | Metastatic Colon Adenocarcinoma | Metastatic Rectal Adenocarcinoma | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Stage IV Colon Cancer | Stage IV Rectal... and other conditionsUnited States